+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Iohexol Injection Market - Global Forecast 2026-2032- Product Image
Iohexol Injection Market - Global Forecast 2026-2032- Product Image
Sale

Iohexol Injection Market - Global Forecast 2026-2032

  • Report

  • 192 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6129150
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Iohexol Injection Market is projected to reach USD 1.16 Billion in 2026. It is expected to continue growing at a CAGR of 7.40%, reaching USD 1.79 Billion by 2032.

Iohexol Injection: Executive Summary and Market Context

Iohexol injection is a nonionic, low-osmolar iodinated contrast medium used to enhance visualization during diagnostic X-ray and computed tomography procedures, including angiography and selected body imaging examinations. Its clinical role is shaped by diagnostic demand, institutional protocols, patient safety requirements, regulatory oversight, and the availability of imaging infrastructure. Adoption decisions generally depend on image quality, route-specific labeling, renal and hypersensitivity risk management, supply reliability, and compatibility with local clinical practice.

Imaging Workflows Are Shifting Toward Safety, Efficiency, and Standardization

The landscape is being transformed by wider use of cross-sectional imaging, greater attention to contrast-associated adverse events, and pressure to improve throughput without compromising diagnostic quality. Hospitals and imaging centers are strengthening screening for kidney function, prior contrast reactions, medication risks, hydration status, and extravasation risk. Standardized protocols, electronic documentation, dose optimization, injector performance, storage controls, and emergency preparedness are increasingly important parts of contrast administration.

Procurement is also becoming more resilient and process-oriented. Providers are evaluating concentration options, packaging, handling requirements, service continuity, and product interchangeability alongside clinical considerations. These changes favor organizations that connect radiology, pharmacy, nursing, procurement, and quality teams through clearly governed protocols.

Artificial Intelligence Amplifies Protocol Design and Diagnostic Workflow Integration

Artificial intelligence is affecting iohexol injection use indirectly by improving imaging triage, protocol selection, acquisition planning, reconstruction, and interpretation support. AI-enabled systems can help prioritize examinations, identify relevant clinical indications, and support consistent selection of scan parameters. When integrated responsibly, these tools may help teams align contrast administration with the intended diagnostic question and reduce avoidable repeat imaging.

AI does not replace clinical judgment or established safety screening. Its cumulative impact depends on validated performance, representative data, interoperability with radiology and electronic health-record systems, auditability, cybersecurity, and human oversight. Industry leaders should treat AI as a workflow and quality tool while retaining clinician accountability for patient assessment, dosing decisions, contraindication review, and response to adverse events.

Regional Insights: Uneven Imaging Capacity Shapes Contrast-Medium Practice

North America combines extensive advanced-imaging capacity with strong emphasis on protocol standardization, renal-risk assessment, adverse-event reporting, and operational efficiency. Europe is influenced by coordinated clinical guidance, national health-system procurement, and variation in reimbursement and imaging access across countries. Asia-Pacific spans highly developed imaging markets and rapidly expanding capacity, making training, infrastructure reliability, and consistent safety practices especially important.

Latin America continues to show substantial differences in access to CT and angiographic services between major urban centers and underserved areas; dependable distribution and workforce development therefore remain central. The Middle East is characterized by concentrated investment in tertiary care and advanced diagnostics in several health systems, alongside differing regulatory and procurement environments. Africa faces wider infrastructure, workforce, and supply-chain constraints, increasing the importance of dependable distribution, appropriate protocols, maintenance support, and practical emergency-readiness programs.

Group Insights: Trade and Policy Blocs Influence Standards and Resilience

ASEAN markets reflect diverse regulatory systems, healthcare financing models, and imaging capacity, so regional coordination can help improve training, documentation, and supply continuity. BRICS members span major differences in domestic manufacturing, public procurement, clinical infrastructure, and access to specialized imaging; local regulatory pathways and hospital capability remain decisive. The European Union benefits from shared regulatory principles and cross-border policy coordination, while national purchasing and reimbursement arrangements still shape implementation.

G7 health systems generally place strong emphasis on evidence-based practice, quality assurance, pharmacovigilance, and digital integration. GCC countries are investing in modern healthcare infrastructure and advanced imaging, with centralized procurement and workforce capability often influencing adoption. NATO members do not constitute a single healthcare market, but many share interoperability, emergency preparedness, and resilient logistics priorities that can affect institutional planning for essential diagnostic supplies.

Country Insights: National Systems Create Distinct Adoption Priorities

Australia and Canada must balance geographically dispersed populations with concentrated advanced-imaging resources, making logistics, telehealth-supported coordination, and standardized protocols important. Brazil, Mexico, India, and Russia encompass major regional differences in healthcare access, procurement, and imaging capability; scalable training, reliable distribution, and adaptable public and private delivery models are relevant priorities. China combines substantial imaging capacity with evolving regulatory, procurement, and domestic supply considerations.

France, Germany, Italy, Spain, and the United Kingdom operate within mature European clinical and regulatory environments, but differ in purchasing structures, reimbursement, capacity pressures, and national guidance. Japan and South Korea have advanced imaging ecosystems and strong technology adoption, with emphasis on workflow efficiency, quality control, and integration with digital hospital systems. Across the United States, institutional protocols, payer conditions, safety governance, and high imaging utilization make operational consistency and patient-centered risk management particularly significant.

Actions for Industry Leaders: Build Safety, Resilience, and Evidence Into Execution

Leaders should maintain route-specific, indication-specific protocols that cover patient screening, renal function assessment, prior reactions, medication review, dose selection, injection technique, extravasation response, and emergency treatment. Training should be recurring and multidisciplinary, with competency checks for radiologists, technologists, nurses, pharmacists, and procurement personnel. Quality dashboards can track protocol adherence, repeat examinations, adverse events, supply interruptions, and response times.

Operationally, organizations should diversify critical supply planning, qualify storage and handling processes, document product substitutions carefully, and coordinate contingency procedures with clinical teams. Digital tools and AI should be introduced through controlled validation, transparent governance, and ongoing monitoring. Regional execution should reflect local regulation, infrastructure, reimbursement, workforce capacity, and patient access rather than relying on a uniform global model.

Research Methodology: Evidence-Led Assessment of Clinical and Operating Conditions

This executive summary uses the supplied market definition-iohexol injection-and synthesizes established clinical, regulatory, operational, and healthcare-system considerations relevant to iodinated contrast administration. The assessment is structured around diagnostic imaging workflows, patient-safety practices, technology integration, procurement resilience, regional conditions, economic groupings, and country-level healthcare characteristics.

Interpretation should be validated against current product labeling, national medicines regulation, professional-society guidance, hospital protocols, pharmacovigilance information, and local procurement rules before implementation. Because clinical standards, supply conditions, and regulatory requirements can change, organizations should periodically refresh the evidence base and distinguish confirmed requirements from institution-specific practices.

Conclusion: Disciplined Contrast Use Supports Reliable Diagnostic Imaging

Iohexol injection remains closely linked to the quality, safety, and efficiency of diagnostic imaging workflows. The most important developments are not limited to product selection: they include stronger patient screening, standardized administration, resilient supply planning, workforce competency, digital integration, and responsible use of AI. Regional and national differences mean that successful execution must be adapted to healthcare capacity, regulation, procurement, and access conditions.

Industry leaders can strengthen outcomes by treating contrast administration as an enterprise-wide clinical process rather than a standalone consumable decision. Consistent governance, measurable quality improvement, validated technology, and locally appropriate implementation provide the clearest foundation for dependable imaging services and safer patient care.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Iohexol Injection Market, by Product Type
7.1. Introduction
7.2. Prefilled Syringes
7.3. Vials
7.4. Bottle
8. Iohexol Injection Market, by Concentration
8.1. Introduction
8.2. 300 mg I/mL
8.3. 350 mg I/mL
8.4. 140 mg I/mL
8.5. 180 mg I/mL
8.6. 240 mg I/mL
9. Iohexol Injection Market, by Route Of Administration
9.1. Introduction
9.2. Intra-Arterial
9.3. Intrathecal
9.4. Intravenous
9.5. Oral
9.6. Rectal
10. Iohexol Injection Market, by Patient Group
10.1. Introduction
10.2. Adult
10.3. Pediatric
10.4. Geriatric
11. Iohexol Injection Market, by Application
11.1. Introduction
11.2. Angiography
11.3. Computed Tomography
11.4. Urography
11.5. Myelography
12. Iohexol Injection Market, by End User
12.1. Introduction
12.2. Ambulatory Surgical Centers
12.3. Clinics
12.4. Diagnostic Imaging Centers
12.5. Hospitals
13. Iohexol Injection Market, by Distribution Channel
13.1. Introduction
13.2. Offline
13.2.1. Hospital Pharmacy
13.2.2. Retail Pharmacy
13.3. Online Pharmacy Platforms
14. Iohexol Injection Market, by Region
14.1. Introduction
14.2. Asia-Pacific
14.3. Europe
14.4. North America
14.5. Latin America
14.6. Africa
14.7. Middle East
15. Iohexol Injection Market, by Group
15.1. Introduction
15.2. NATO
15.3. G7
15.4. European Union
15.5. BRICS
15.6. ASEAN
15.7. GCC
16. Iohexol Injection Market, by Country
16.1. Introduction
16.2. United States
16.3. China
16.4. Germany
16.5. Japan
16.6. India
16.7. United Kingdom
16.8. France
16.9. Australia
16.10. Italy
16.11. Canada
16.12. South Korea
16.13. Brazil
16.14. Russia
16.15. Mexico
16.16. Spain
17. Competitive Landscape
17.1. Market Share Analysis, 2025
17.2. Market Concentration Analysis, 2025
17.2.1. Concentration Ratio (CR)
17.2.2. Herfindahl Hirschman Index (HHI)
17.3. Recent Developments & Impact Analysis, 2025
17.4. Product Portfolio Analysis, 2025
17.5. Benchmarking Analysis, 2025
18. Company Profiles
18.1. GE Healthcare Technologies, Inc.
18.2. Jiangsu Hengrui Medicine Co., Ltd.
18.3. Yangtze River Pharmaceutical Group
18.4. CISEN PHARMACEUTICAL Co Ltd
18.5. Amneal Pharmaceuticals, Inc.
18.6. Beijing Beilu Pharmaceutical Co., Ltd.
18.7. Unijules Life Sciences Ltd.
18.8. Amber LifeSciences Pvt Ltd
18.9. Imax Diagnostic Imaging Ltd.
18.10. Intelicure Lifesciences
18.11. JB Chemicals & Pharmaceuticals Ltd.
18.12. Jodas Expoim Pvt. Ltd
18.13. Maya Biotech
19. Key Experts
LIST OF FIGURES
FIGURE 1. Global Iohexol Injection Market, Years Considered for the Study
FIGURE 2. Global Iohexol Injection Market, Research Design
FIGURE 3. Global Iohexol Injection Market, Research Framework
FIGURE 4. Global Iohexol Injection Market, Data Triangulation
FIGURE 5. Global Iohexol Injection Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Iohexol Injection Market Size, by Product Type, 2025 vs 2032 (%)
FIGURE 7. Global Iohexol Injection Market Size, by Product Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Iohexol Injection Market Size, by Concentration, 2025 vs 2032 (%)
FIGURE 9. Global Iohexol Injection Market Size, by Concentration, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Iohexol Injection Market Size, by Route Of Administration, 2025 vs 2032 (%)
FIGURE 11. Global Iohexol Injection Market Size, by Route Of Administration, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Iohexol Injection Market Size, by Patient Group, 2025 vs 2032 (%)
FIGURE 13. Global Iohexol Injection Market Size, by Patient Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Iohexol Injection Market Size, by Application, 2025 vs 2032 (%)
FIGURE 15. Global Iohexol Injection Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Iohexol Injection Market Size, by End User, 2025 vs 2032 (%)
FIGURE 17. Global Iohexol Injection Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Iohexol Injection Market Size, by Distribution Channel, 2025 vs 2032 (%)
FIGURE 19. Global Iohexol Injection Market Size, by Distribution Channel, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 20. Global Iohexol Injection Market Size, by Region, 2025 vs 2032 (%)
FIGURE 21. Global Iohexol Injection Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 22. Global Iohexol Injection Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 23. Global Iohexol Injection Market Size, by Country, 2025 vs 2032 (%)
FIGURE 24. Global Iohexol Injection Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 25. Global Iohexol Injection Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Iohexol Injection Market Segmentation & Coverage
TABLE 2. Global Iohexol Injection Market Size, 2017-2032 (USD Million)
TABLE 3. Global Iohexol Injection Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 4. Global Prefilled Syringes Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Prefilled Syringes Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Prefilled Syringes Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Vials Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Vials Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Vials Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Bottle Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Bottle Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Bottle Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Iohexol Injection Market Size, by Concentration, 2017-2032 (USD Million)
TABLE 14. Global 300 mg I/mL Market Size, by Region, 2017-2032 (USD Million)
TABLE 15. Global 300 mg I/mL Market Size, by Group, 2017-2032 (USD Million)
TABLE 16. Global 300 mg I/mL Market Size, by Country, 2017-2032 (USD Million)
TABLE 17. Global 350 mg I/mL Market Size, by Region, 2017-2032 (USD Million)
TABLE 18. Global 350 mg I/mL Market Size, by Group, 2017-2032 (USD Million)
TABLE 19. Global 350 mg I/mL Market Size, by Country, 2017-2032 (USD Million)
TABLE 20. Global 140 mg I/mL Market Size, by Region, 2017-2032 (USD Million)
TABLE 21. Global 140 mg I/mL Market Size, by Group, 2017-2032 (USD Million)
TABLE 22. Global 140 mg I/mL Market Size, by Country, 2017-2032 (USD Million)
TABLE 23. Global 180 mg I/mL Market Size, by Region, 2017-2032 (USD Million)
TABLE 24. Global 180 mg I/mL Market Size, by Group, 2017-2032 (USD Million)
TABLE 25. Global 180 mg I/mL Market Size, by Country, 2017-2032 (USD Million)
TABLE 26. Global 240 mg I/mL Market Size, by Region, 2017-2032 (USD Million)
TABLE 27. Global 240 mg I/mL Market Size, by Group, 2017-2032 (USD Million)
TABLE 28. Global 240 mg I/mL Market Size, by Country, 2017-2032 (USD Million)
TABLE 29. Global Iohexol Injection Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 30. Global Intra-Arterial Market Size, by Region, 2017-2032 (USD Million)
TABLE 31. Global Intra-Arterial Market Size, by Group, 2017-2032 (USD Million)
TABLE 32. Global Intra-Arterial Market Size, by Country, 2017-2032 (USD Million)
TABLE 33. Global Intrathecal Market Size, by Region, 2017-2032 (USD Million)
TABLE 34. Global Intrathecal Market Size, by Group, 2017-2032 (USD Million)
TABLE 35. Global Intrathecal Market Size, by Country, 2017-2032 (USD Million)
TABLE 36. Global Intravenous Market Size, by Region, 2017-2032 (USD Million)
TABLE 37. Global Intravenous Market Size, by Group, 2017-2032 (USD Million)
TABLE 38. Global Intravenous Market Size, by Country, 2017-2032 (USD Million)
TABLE 39. Global Oral Market Size, by Region, 2017-2032 (USD Million)
TABLE 40. Global Oral Market Size, by Group, 2017-2032 (USD Million)
TABLE 41. Global Oral Market Size, by Country, 2017-2032 (USD Million)
TABLE 42. Global Rectal Market Size, by Region, 2017-2032 (USD Million)
TABLE 43. Global Rectal Market Size, by Group, 2017-2032 (USD Million)
TABLE 44. Global Rectal Market Size, by Country, 2017-2032 (USD Million)
TABLE 45. Global Iohexol Injection Market Size, by Patient Group, 2017-2032 (USD Million)
TABLE 46. Global Adult Market Size, by Region, 2017-2032 (USD Million)
TABLE 47. Global Adult Market Size, by Group, 2017-2032 (USD Million)
TABLE 48. Global Adult Market Size, by Country, 2017-2032 (USD Million)
TABLE 49. Global Pediatric Market Size, by Region, 2017-2032 (USD Million)
TABLE 50. Global Pediatric Market Size, by Group, 2017-2032 (USD Million)
TABLE 51. Global Pediatric Market Size, by Country, 2017-2032 (USD Million)
TABLE 52. Global Geriatric Market Size, by Region, 2017-2032 (USD Million)
TABLE 53. Global Geriatric Market Size, by Group, 2017-2032 (USD Million)
TABLE 54. Global Geriatric Market Size, by Country, 2017-2032 (USD Million)
TABLE 55. Global Iohexol Injection Market Size, by Application, 2017-2032 (USD Million)
TABLE 56. Global Angiography Market Size, by Region, 2017-2032 (USD Million)
TABLE 57. Global Angiography Market Size, by Group, 2017-2032 (USD Million)
TABLE 58. Global Angiography Market Size, by Country, 2017-2032 (USD Million)
TABLE 59. Global Computed Tomography Market Size, by Region, 2017-2032 (USD Million)
TABLE 60. Global Computed Tomography Market Size, by Group, 2017-2032 (USD Million)
TABLE 61. Global Computed Tomography Market Size, by Country, 2017-2032 (USD Million)
TABLE 62. Global Urography Market Size, by Region, 2017-2032 (USD Million)
TABLE 63. Global Urography Market Size, by Group, 2017-2032 (USD Million)
TABLE 64. Global Urography Market Size, by Country, 2017-2032 (USD Million)
TABLE 65. Global Myelography Market Size, by Region, 2017-2032 (USD Million)
TABLE 66. Global Myelography Market Size, by Group, 2017-2032 (USD Million)
TABLE 67. Global Myelography Market Size, by Country, 2017-2032 (USD Million)
TABLE 68. Global Iohexol Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 69. Global Ambulatory Surgical Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 70. Global Ambulatory Surgical Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 71. Global Ambulatory Surgical Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 72. Global Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 73. Global Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 74. Global Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 75. Global Diagnostic Imaging Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 76. Global Diagnostic Imaging Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 77. Global Diagnostic Imaging Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 78. Global Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 79. Global Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 80. Global Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 81. Global Iohexol Injection Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 82. Global Offline Market Size, by Region, 2017-2032 (USD Million)
TABLE 83. Global Offline Market Size, by Group, 2017-2032 (USD Million)
TABLE 84. Global Offline Market Size, by Country, 2017-2032 (USD Million)
TABLE 85. Global Hospital Pharmacy Market Size, by Region, 2017-2032 (USD Million)
TABLE 86. Global Hospital Pharmacy Market Size, by Group, 2017-2032 (USD Million)
TABLE 87. Global Hospital Pharmacy Market Size, by Country, 2017-2032 (USD Million)
TABLE 88. Global Retail Pharmacy Market Size, by Region, 2017-2032 (USD Million)
TABLE 89. Global Retail Pharmacy Market Size, by Group, 2017-2032 (USD Million)
TABLE 90. Global Retail Pharmacy Market Size, by Country, 2017-2032 (USD Million)
TABLE 91. Global Online Pharmacy Platforms Market Size, by Region, 2017-2032 (USD Million)
TABLE 92. Global Online Pharmacy Platforms Market Size, by Group, 2017-2032 (USD Million)
TABLE 93. Global Online Pharmacy Platforms Market Size, by Country, 2017-2032 (USD Million)
TABLE 94. Global Iohexol Injection Market Size, by Region, 2017-2032 (USD Million)
TABLE 95. Asia-Pacific Iohexol Injection Market Size, by Region, 2017-2032 (USD Million)
TABLE 96. Asia-Pacific Iohexol Injection Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 97. Asia-Pacific Iohexol Injection Market Size, by Concentration, 2017-2032 (USD Million)
TABLE 98. Asia-Pacific Iohexol Injection Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 99. Asia-Pacific Iohexol Injection Market Size, by Patient Group, 2017-2032 (USD Million)
TABLE 100. Asia-Pacific Iohexol Injection Market Size, by Application, 2017-2032 (USD Million)
TABLE 101. Asia-Pacific Iohexol Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 102. Asia-Pacific Iohexol Injection Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 103. Asia-Pacific Iohexol Injection Market Size, by Offline, 2017-2032 (USD Million)
TABLE 104. Europe Iohexol Injection Market Size, by Region, 2017-2032 (USD Million)
TABLE 105. Europe Iohexol Injection Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 106. Europe Iohexol Injection Market Size, by Concentration, 2017-2032 (USD Million)
TABLE 107. Europe Iohexol Injection Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 108. Europe Iohexol Injection Market Size, by Patient Group, 2017-2032 (USD Million)
TABLE 109. Europe Iohexol Injection Market Size, by Application, 2017-2032 (USD Million)
TABLE 110. Europe Iohexol Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 111. Europe Iohexol Injection Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 112. Europe Iohexol Injection Market Size, by Offline, 2017-2032 (USD Million)
TABLE 113. North America Iohexol Injection Market Size, by Region, 2017-2032 (USD Million)
TABLE 114. North America Iohexol Injection Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 115. North America Iohexol Injection Market Size, by Concentration, 2017-2032 (USD Million)
TABLE 116. North America Iohexol Injection Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 117. North America Iohexol Injection Market Size, by Patient Group, 2017-2032 (USD Million)
TABLE 118. North America Iohexol Injection Market Size, by Application, 2017-2032 (USD Million)
TABLE 119. North America Iohexol Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 120. North America Iohexol Injection Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 121. North America Iohexol Injection Market Size, by Offline, 2017-2032 (USD Million)
TABLE 122. Latin America Iohexol Injection Market Size, by Region, 2017-2032 (USD Million)
TABLE 123. Latin America Iohexol Injection Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 124. Latin America Iohexol Injection Market Size, by Concentration, 2017-2032 (USD Million)
TABLE 125. Latin America Iohexol Injection Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 126. Latin America Iohexol Injection Market Size, by Patient Group, 2017-2032 (USD Million)
TABLE 127. Latin America Iohexol Injection Market Size, by Application, 2017-2032 (USD Million)
TABLE 128. Latin America Iohexol Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 129. Latin America Iohexol Injection Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 130. Latin America Iohexol Injection Market Size, by Offline, 2017-2032 (USD Million)
TABLE 131. Africa Iohexol Injection Market Size, by Region, 2017-2032 (USD Million)
TABLE 132. Africa Iohexol Injection Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 133. Africa Iohexol Injection Market Size, by Concentration, 2017-2032 (USD Million)
TABLE 134. Africa Iohexol Injection Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 135. Africa Iohexol Injection Market Size, by Patient Group, 2017-2032 (USD Million)
TABLE 136. Africa Iohexol Injection Market Size, by Application, 2017-2032 (USD Million)
TABLE 137. Africa Iohexol Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 138. Africa Iohexol Injection Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 139. Africa Iohexol Injection Market Size, by Offline, 2017-2032 (USD Million)
TABLE 140. Middle East Iohexol Injection Market Size, by Region, 2017-2032 (USD Million)
TABLE 141. Middle East Iohexol Injection Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 142. Middle East Iohexol Injection Market Size, by Concentration, 2017-2032 (USD Million)
TABLE 143. Middle East Iohexol Injection Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 144. Middle East Iohexol Injection Market Size, by Patient Group, 2017-2032 (USD Million)
TABLE 145. Middle East Iohexol Injection Market Size, by Application, 2017-2032 (USD Million)
TABLE 146. Middle East Iohexol Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 147. Middle East Iohexol Injection Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 148. Middle East Iohexol Injection Market Size, by Offline, 2017-2032 (USD Million)
TABLE 149. Global Iohexol Injection Market Size, by Group, 2017-2032 (USD Million)
TABLE 150. NATO Iohexol Injection Market Size, by Group, 2017-2032 (USD Million)
TABLE 151. NATO Iohexol Injection Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 152. NATO Iohexol Injection Market Size, by Concentration, 2017-2032 (USD Million)
TABLE 153. NATO Iohexol Injection Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 154. NATO Iohexol Injection Market Size, by Patient Group, 2017-2032 (USD Million)
TABLE 155. NATO Iohexol Injection Market Size, by Application, 2017-2032 (USD Million)
TABLE 156. NATO Iohexol Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 157. NATO Iohexol Injection Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 158. NATO Iohexol Injection Market Size, by Offline, 2017-2032 (USD Million)
TABLE 159. G7 Iohexol Injection Market Size, by Group, 2017-2032 (USD Million)
TABLE 160. G7 Iohexol Injection Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 161. G7 Iohexol Injection Market Size, by Concentration, 2017-2032 (USD Million)
TABLE 162. G7 Iohexol Injection Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 163. G7 Iohexol Injection Market Size, by Patient Group, 2017-2032 (USD Million)
TABLE 164. G7 Iohexol Injection Market Size, by Application, 2017-2032 (USD Million)
TABLE 165. G7 Iohexol Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 166. G7 Iohexol Injection Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 167. G7 Iohexol Injection Market Size, by Offline, 2017-2032 (USD Million)
TABLE 168. European Union Iohexol Injection Market Size, by Group, 2017-2032 (USD Million)
TABLE 169. European Union Iohexol Injection Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 170. European Union Iohexol Injection Market Size, by Concentration, 2017-2032 (USD Million)
TABLE 171. European Union Iohexol Injection Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 172. European Union Iohexol Injection Market Size, by Patient Group, 2017-2032 (USD Million)
TABLE 173. European Union Iohexol Injection Market Size, by Application, 2017-2032 (USD Million)
TABLE 174. European Union Iohexol Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 175. European Union Iohexol Injection Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 176. European Union Iohexol Injection Market Size, by Offline, 2017-2032 (USD Million)
TABLE 177. BRICS Iohexol Injection Market Size, by Group, 2017-2032 (USD Million)
TABLE 178. BRICS Iohexol Injection Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 179. BRICS Iohexol Injection Market Size, by Concentration, 2017-2032 (USD Million)
TABLE 180. BRICS Iohexol Injection Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 181. BRICS Iohexol Injection Market Size, by Patient Group, 2017-2032 (USD Million)
TABLE 182. BRICS Iohexol Injection Market Size, by Application, 2017-2032 (USD Million)
TABLE 183. BRICS Iohexol Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 184. BRICS Iohexol Injection Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 185. BRICS Iohexol Injection Market Size, by Offline, 2017-2032 (USD Million)
TABLE 186. ASEAN Iohexol Injection Market Size, by Group, 2017-2032 (USD Million)
TABLE 187. ASEAN Iohexol Injection Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 188. ASEAN Iohexol Injection Market Size, by Concentration, 2017-2032 (USD Million)
TABLE 189. ASEAN Iohexol Injection Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 190. ASEAN Iohexol Injection Market Size, by Patient Group, 2017-2032 (USD Million)
TABLE 191. ASEAN Iohexol Injection Market Size, by Application, 2017-2032 (USD Million)
TABLE 192. ASEAN Iohexol Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 193. ASEAN Iohexol Injection Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 194. ASEAN Iohexol Injection Market Size, by Offline, 2017-2032 (USD Million)
TABLE 195. GCC Iohexol Injection Market Size, by Group, 2017-2032 (USD Million)
TABLE 196. GCC Iohexol Injection Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 197. GCC Iohexol Injection Market Size, by Concentration, 2017-2032 (USD Million)
TABLE 198. GCC Iohexol Injection Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 199. GCC Iohexol Injection Market Size, by Patient Group, 2017-2032 (USD Million)
TABLE 200. GCC Iohexol Injection Market Size, by Application, 2017-2032 (USD Million)
TABLE 201. GCC Iohexol Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 202. GCC Iohexol Injection Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 203. GCC Iohexol Injection Market Size, by Offline, 2017-2032 (USD Million)
TABLE 204. Global Iohexol Injection Market Size, by Country, 2017-2032 (USD Million)
TABLE 205. United States Iohexol Injection Market Size, 2017-2032 (USD Million)
TABLE 206. United States Iohexol Injection Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 207. United States Iohexol Injection Market Size, by Concentration, 2017-2032 (USD Million)
TABLE 208. United States Iohexol Injection Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 209. United States Iohexol Injection Market Size, by Patient Group, 2017-2032 (USD Million)
TABLE 210. United States Iohexol Injection Market Size, by Application, 2017-2032 (USD Million)
TABLE 211. United States Iohexol Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 212. United States Iohexol Injection Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 213. United States Iohexol Injection Market Size, by Offline, 2017-2032 (USD Million)
TABLE 214. China Iohexol Injection Market Size, 2017-2032 (USD Million)
TABLE 215. China Iohexol Injection Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 216. China Iohexol Injection Market Size, by Concentration, 2017-2032 (USD Million)
TABLE 217. China Iohexol Injection Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 218. China Iohexol Injection Market Size, by Patient Group, 2017-2032 (USD Million)
TABLE 219. China Iohexol Injection Market Size, by Application, 2017-2032 (USD Million)
TABLE 220. China Iohexol Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 221. China Iohexol Injection Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 222. China Iohexol Injection Market Size, by Offline, 2017-2032 (USD Million)
TABLE 223. Germany Iohexol Injection Market Size, 2017-2032 (USD Million)
TABLE 224. Germany Iohexol Injection Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 225. Germany Iohexol Injection Market Size, by Concentration, 2017-2032 (USD Million)
TABLE 226. Germany Iohexol Injection Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 227. Germany Iohexol Injection Market Size, by Patient Group, 2017-2032 (USD Million)
TABLE 228. Germany Iohexol Injection Market Size, by Application, 2017-2032 (USD Million)
TABLE 229. Germany Iohexol Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 230. Germany Iohexol Injection Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 231. Germany Iohexol Injection Market Size, by Offline, 2017-2032 (USD Million)
TABLE 232. Japan Iohexol Injection Market Size, 2017-2032 (USD Million)
TABLE 233. Japan Iohexol Injection Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 234. Japan Iohexol Injection Market Size, by Concentration, 2017-2032 (USD Million)
TABLE 235. Japan Iohexol Injection Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 236. Japan Iohexol Injection Market Size, by Patient Group, 2017-2032 (USD Million)
TABLE 237. Japan Iohexol Injection Market Size, by Application, 2017-2032 (USD Million)
TABLE 238. Japan Iohexol Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 239. Japan Iohexol Injection Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 240. Japan Iohexol Injection Market Size, by Offline, 2017-2032 (USD Million)
TABLE 241. India Iohexol Injection Market Size, 2017-2032 (USD Million)
TABLE 242. India Iohexol Injection Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 243. India Iohexol Injection Market Size, by Concentration, 2017-2032 (USD Million)
TABLE 244. India Iohexol Injection Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 245. India Iohexol Injection Market Size, by Patient Group, 2017-2032 (USD Million)
TABLE 246. India Iohexol Injection Market Size, by Application, 2017-2032 (USD Million)
TABLE 247. India Iohexol Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 248. India Iohexol Injection Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 249. India Iohexol Injection Market Size, by Offline, 2017-2032 (USD Million)
TABLE 250. United Kingdom Iohexol Injection Market Size, 2017-2032 (USD Million)
TABLE 251. United Kingdom Iohexol Injection Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 252. United Kingdom Iohexol Injection Market Size, by Concentration, 2017-2032 (USD Million)
TABLE 253. United Kingdom Iohexol Injection Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 254. United Kingdom Iohexol Injection Market Size, by Patient Group, 2017-2032 (USD Million)
TABLE 255. United Kingdom Iohexol Injection Market Size, by Application, 2017-2032 (USD Million)
TABLE 256. United Kingdom Iohexol Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 257. United Kingdom Iohexol Injection Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 258. United Kingdom Iohexol Injection Market Size, by Offline, 2017-2032 (USD Million)
TABLE 259. France Iohexol Injection Market Size, 2017-2032 (USD Million)
TABLE 260. France Iohexol Injection Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 261. France Iohexol Injection Market Size, by Concentration, 2017-2032 (USD Million)
TABLE 262. France Iohexol Injection Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 263. France Iohexol Injection Market Size, by Patient Group, 2017-2032 (USD Million)
TABLE 264. France Iohexol Injection Market Size, by Application, 2017-2032 (USD Million)
TABLE 265. France Iohexol Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 266. France Iohexol Injection Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 267. France Iohexol Injection Market Size, by Offline, 2017-2032 (USD Million)
TABLE 268. Australia Iohexol Injection Market Size, 2017-2032 (USD Million)
TABLE 269. Australia Iohexol Injection Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 270. Australia Iohexol Injection Market Size, by Concentration, 2017-2032 (USD Million)
TABLE 271. Australia Iohexol Injection Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 272. Australia Iohexol Injection Market Size, by Patient Group, 2017-2032 (USD Million)
TABLE 273. Australia Iohexol Injection Market Size, by Application, 2017-2032 (USD Million)
TABLE 274. Australia Iohexol Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 275. Australia Iohexol Injection Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 276. Australia Iohexol Injection Market Size, by Offline, 2017-2032 (USD Million)
TABLE 277. Italy Iohexol Injection Market Size, 2017-2032 (USD Million)
TABLE 278. Italy Iohexol Injection Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 279. Italy Iohexol Injection Market Size, by Concentration, 2017-2032 (USD Million)
TABLE 280. Italy Iohexol Injection Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 281. Italy Iohexol Injection Market Size, by Patient Group, 2017-2032 (USD Million)
TABLE 282. Italy Iohexol Injection Market Size, by Application, 2017-2032 (USD Million)
TABLE 283. Italy Iohexol Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 284. Italy Iohexol Injection Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 285. Italy Iohexol Injection Market Size, by Offline, 2017-2032 (USD Million)
TABLE 286. Canada Iohexol Injection Market Size, 2017-2032 (USD Million)
TABLE 287. Canada Iohexol Injection Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 288. Canada Iohexol Injection Market Size, by Concentration, 2017-2032 (USD Million)
TABLE 289. Canada Iohexol Injection Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 290. Canada Iohexol Injection Market Size, by Patient Group, 2017-2032 (USD Million)
TABLE 291. Canada Iohexol Injection Market Size, by Application, 2017-2032 (USD Million)
TABLE 292. Canada Iohexol Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 293. Canada Iohexol Injection Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 294. Canada Iohexol Injection Market Size, by Offline, 2017-2032 (USD Million)
TABLE 295. South Korea Iohexol Injection Market Size, 2017-2032 (USD Million)
TABLE 296. South Korea Iohexol Injection Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 297. South Korea Iohexol Injection Market Size, by Concentration, 2017-2032 (USD Million)
TABLE 298. South Korea Iohexol Injection Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 299. South Korea Iohexol Injection Market Size, by Patient Group, 2017-2032 (USD Million)
TABLE 300. South Korea Iohexol Injection Market Size, by Application, 2017-2032 (USD Million)
TABLE 301. South Korea Iohexol Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 302. South Korea Iohexol Injection Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 303. South Korea Iohexol Injection Market Size, by Offline, 2017-2032 (USD Million)
TABLE 304. Brazil Iohexol Injection Market Size, 2017-2032 (USD Million)
TABLE 305. Brazil Iohexol Injection Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 306. Brazil Iohexol Injection Market Size, by Concentration, 2017-2032 (USD Million)
TABLE 307. Brazil Iohexol Injection Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 308. Brazil Iohexol Injection Market Size, by Patient Group, 2017-2032 (USD Million)
TABLE 309. Brazil Iohexol Injection Market Size, by Application, 2017-2032 (USD Million)
TABLE 310. Brazil Iohexol Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 311. Brazil Iohexol Injection Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 312. Brazil Iohexol Injection Market Size, by Offline, 2017-2032 (USD Million)
TABLE 313. Russia Iohexol Injection Market Size, 2017-2032 (USD Million)
TABLE 314. Russia Iohexol Injection Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 315. Russia Iohexol Injection Market Size, by Concentration, 2017-2032 (USD Million)
TABLE 316. Russia Iohexol Injection Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 317. Russia Iohexol Injection Market Size, by Patient Group, 2017-2032 (USD Million)
TABLE 318. Russia Iohexol Injection Market Size, by Application, 2017-2032 (USD Million)
TABLE 319. Russia Iohexol Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 320. Russia Iohexol Injection Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 321. Russia Iohexol Injection Market Size, by Offline, 2017-2032 (USD Million)
TABLE 322. Mexico Iohexol Injection Market Size, 2017-2032 (USD Million)
TABLE 323. Mexico Iohexol Injection Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 324. Mexico Iohexol Injection Market Size, by Concentration, 2017-2032 (USD Million)
TABLE 325. Mexico Iohexol Injection Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 326. Mexico Iohexol Injection Market Size, by Patient Group, 2017-2032 (USD Million)
TABLE 327. Mexico Iohexol Injection Market Size, by Application, 2017-2032 (USD Million)
TABLE 328. Mexico Iohexol Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 329. Mexico Iohexol Injection Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 330. Mexico Iohexol Injection Market Size, by Offline, 2017-2032 (USD Million)
TABLE 331. Spain Iohexol Injection Market Size, 2017-2032 (USD Million)
TABLE 332. Spain Iohexol Injection Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 333. Spain Iohexol Injection Market Size, by Concentration, 2017-2032 (USD Million)
TABLE 334. Spain Iohexol Injection Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 335. Spain Iohexol Injection Market Size, by Patient Group, 2017-2032 (USD Million)
TABLE 336. Spain Iohexol Injection Market Size, by Application, 2017-2032 (USD Million)
TABLE 337. Spain Iohexol Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 338. Spain Iohexol Injection Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 339. Spain Iohexol Injection Market Size, by Offline, 2017-2032 (USD Million)
TABLE 340. Global Iohexol Injection Market Share, by Key Player, 2025
TABLE 341. Global Iohexol Injection Market, Key Experts

Companies Mentioned

  • GE Healthcare Technologies, Inc.
  • Jiangsu Hengrui Medicine Co., Ltd.
  • Yangtze River Pharmaceutical Group
  • CISEN PHARMACEUTICAL Co Ltd
  • Amneal Pharmaceuticals, Inc.
  • Beijing Beilu Pharmaceutical Co., Ltd.
  • Unijules Life Sciences Ltd.
  • Amber LifeSciences Pvt Ltd
  • Imax Diagnostic Imaging Ltd.
  • Intelicure Lifesciences
  • JB Chemicals & Pharmaceuticals Ltd.
  • Jodas Expoim Pvt. Ltd
  • Maya Biotech

Related Topics

Related Reports

Iohexol Injection Market Outlook 2026-2034: Market Share and Growth Analysis - Product Image

Iohexol Injection Market Outlook 2026-2034: Market Share and Growth Analysis

  • Report
  • 160 Pages
  • Global
From
Iohexol (CAS 66108-95-0) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029 - Product Image

Iohexol (CAS 66108-95-0) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029

  • Report
  • 50 Pages
  • Global
From
Drotavirin Hydrochloride Injection Market - Global Forecast 2026-2032 - Product Image

Drotavirin Hydrochloride Injection Market - Global Forecast 2026-2032

  • Report
  • 180 Pages
  • Global
From
Diazapam Injection Market - Global Forecast 2026-2032 - Product Image

Diazapam Injection Market - Global Forecast 2026-2032

  • Report
  • 190 Pages
  • Global
From
Sodium Hyaluronate Injection for Osteoarthritis Global Market Insights 2025, Analysis and Forecast to 2030, by Manufacturers, Regions, Technology, Application, Product Type - Product Image

Sodium Hyaluronate Injection for Osteoarthritis Global Market Insights 2025, Analysis and Forecast to 2030, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • 112 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.